KR20160021086A - Pharbitis nil (l.) choisy extract-containing composition for preventing hair loss and promoting hair growth - Google Patents

Pharbitis nil (l.) choisy extract-containing composition for preventing hair loss and promoting hair growth Download PDF

Info

Publication number
KR20160021086A
KR20160021086A KR1020157031360A KR20157031360A KR20160021086A KR 20160021086 A KR20160021086 A KR 20160021086A KR 1020157031360 A KR1020157031360 A KR 1020157031360A KR 20157031360 A KR20157031360 A KR 20157031360A KR 20160021086 A KR20160021086 A KR 20160021086A
Authority
KR
South Korea
Prior art keywords
hair
composition
promoting
hair growth
hair loss
Prior art date
Application number
KR1020157031360A
Other languages
Korean (ko)
Other versions
KR101733552B1 (en
Inventor
김광수
Original Assignee
김성욱
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김성욱 filed Critical 김성욱
Publication of KR20160021086A publication Critical patent/KR20160021086A/en
Application granted granted Critical
Publication of KR101733552B1 publication Critical patent/KR101733552B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Abstract

본 발명은 나팔꽃(Pharbitis nil (L.) Choisy)의 꽃추출물을 유효성분으로 함유하는 탈모 방지 및 발모 촉진용 조성물에 관한 것으로서, 본 발명에 따른 조성물은 장기간 사용에도 부작용이 없으면서도 탈모 방지 및 발모 촉진에 우수한 효과가 있다The present invention relates to a composition for preventing hair loss and promoting hair growth comprising a flower extract of Pharbitis nil (L.) Choisy as an active ingredient. The composition according to the present invention is useful for prevention of hair loss and hair growth Excellent effect on promotion

Description

나팔꽃 추출물을 함유하는 탈모방지 및 발모촉진용 조성물{PHARBITIS NIL (L.) CHOISY EXTRACT-CONTAINING COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH}[0001] PHARBITIS NIL (L.) CHOISY EXTRACT-CONTAINING COMPOSITION FOR PREVENTING HAIR LOSS AND PROMOTING HAIR GROWTH [0002]

본 발명은 탈모방지 및 발모촉진용 조성물에 관한 것으로서, 보다 구체적으로는, 나팔꽃(Pharbitis nil (L.) Choisy; Ipomoea nil (L.) Roth)의 꽃추출물을 유효성분으로 함유하는 탈모방지 및 발모촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing hair loss and promoting hair growth. More specifically, the present invention relates to a composition for preventing and treating hair loss, comprising a flower extract of Pharbitis nil (L.) Choisy ( Ipomoea nil (L.) Roth) And more particularly to a composition for promoting hair growth.

인체의 모발은 약 130만개 이상, 두발은 10만~15만개로, 각각의 모발은 서로 다른 주기를 가지며 성장기(anagen, the active growth phase), 퇴행기(catagen , the apoptotic regression phase), 휴지기(telogen, the resting phase)의 3단계 주기를 거쳐 성장, 유지 및 탈락한다. 이러한 주기는 3~6년에 걸쳐 반복되는데, 그 결과 정상적으로 하루평균 50~100개의 모발이 탈락하게 된다. 일반적으로 '탈모'라 함은 머리카락이나 털이 어떤 원인에 의하여 정상보다 적거나 없는 상태를 의미한다.The hair of the human body has more than 1.3 million hair and the hair of 100 ~ 150 thousand hair. Each hair has a different cycle, and the anagen, the active growth phase, the apoptotic regression phase, telogen , and the resting phase). This cycle repeats over 3 to 6 years, resulting in an average of 50 to 100 hairs dropped on average per day. In general, hair loss refers to a state in which hair or hair is less or no longer normal due to any cause.

오늘날 탈모의 원인으로 남성호르몬의 작용과 같은 내적 요인 또는 일상생활에서의 정신적인 스트레스, 두피에서의 과산화지질의 축적과 같은 외적 요인이 있으며, 이러한 요인들이 복잡하게 관여하여 탈모증상을 나타내는 것으로 알려져 있다. 최근에는 남성형 탈모뿐만 아니라 식생활의 변화, 사회 환경 등에 의한 스트레스의 증가로 인해 여성의 탈모 인구도 증가하고 있는 추세이며, 상기와 같은 두피 및 모발의 이상 증상으로 고민하는 인구가 점점 늘어나고 있으며 그 연령 또한 낮아지고 있다.Today, hair loss is caused by internal factors such as male hormone action, mental stress in daily life, accumulation of lipid peroxidation in the scalp, and these factors are known to be associated with hair loss symptoms . Recently, the hair loss population of the female is increasing due to the increase of the stress due to the change of the eating habits, the social environment and the like as well as the male hair loss, and the population suffering from the abnormal symptoms of the scalp and the hair is increasing, It is getting lower.

상기 여러 요인들 중, 남성호르몬이 탈모에 미치는 영향을 살펴보면, 테스토스테론이 체내의 5알파-리덕타아제(5α-reductase) 효소와 결합하여 디히드록시테스토스테론(dihydroxytestosterone: 이하 ‘DHT’라 함)을 생성하게 되고, 이 DHT는 모근의 안드로겐 수용체와 결합하여 모근의 모낭 생성을 저해하는데 지배적인 영향을 주게 된다. 따라서, 5α-리덕타아제 효소의 억제제를 사용하여 탈모방지 효과 물질을 개발하려는 연구들이 현재 활발히 진행되고 있다.Of the above factors, male hormone affects hair loss. Testosterone binds to 5 alpha-reductase enzyme in the body to produce dihydroxytestosterone (DHT) And this DHT binds to the androgen receptor of hair roots and has a dominant influence on inhibiting hair follicle production of hair follicles. Therefore, studies are currently under way to develop anti-hair-loss agents using inhibitors of 5α-reductase enzyme.

현재 시판중인 발모제로는 미국 업존사의 미녹시딜(minoxidil), 이태리 크리노스(Crinos, Co.)사의 트리코사카라이드(trichosaccharide)등을 주성분으로 하는 제제가 사용되고 있으나 뚜렷한 효과의 부재 및 부작용 문제가 대두되고 있다. 또한 머크사에 의해 전립선비대증 치료제로 개발되었다가 탈모증 치료에 도입된 프로페시아(Propecia, 성분명: 피나스테라이드(finasteride))는 모낭에서 남성호르몬 테스토스테론 대사에 작용하는 효소인 5α-리덕타제(5-α-reductase)의 활성을 억제시키는 물질로 알려져 있으나 지속적으로 복용해야 하고, 성기능 감소나 알레르기, 우울증 등 부작용을 유발하는 문제점을 안고 있다.Minoxidil in the United States of America and trichosaccharide in Crinos Co. are used as the hair growth promoters currently marketed. However, there is a problem of lack of clear effect and side effects . Propecia (Finasteride), which was developed by Merck as a treatment for prostate enlargement, was introduced into the treatment of alopecia. It is known that 5-α-reductase, an enzyme that acts on male hormone testosterone metabolism in hair follicles, ), But they have to be taken continuously and have side effects such as sexual dysfunction, allergy and depression.

또한, 여성 탈모는 두피가 두개골보다 발달이 빨리 정지되기 때문에 노화가 진행됨에 따라 두피에 혈류장애가 발생하는 것이 원인 중 하나라고 알려져 있는 등 복합적인 원인에 의해 발생하는 것으로 알려져 있기 때문에, 위와 같은 호르몬 억제 등의 협소적인 치료는 근시안적인 처방에 불과하다는 문제점이 있었다.In addition, it is known that female hair loss occurs due to multiple causes, such as that it is known to be one of the causes of blood flow disorder in the scalp as the aging proceeds as the scalp rapidly stops its development than the skull, and therefore, And the like, is a short-sighted prescription.

이러한 문제점을 고려하여, 천연물 유래의 추출물을 유효성분으로 함유함으로써 독성이 없으면서, 장기사용에도 부작용이 발생하지 않는 탈모 방지 또는 모발 성장 촉진용 조성물에 관한 연구가 활발히 진행되고 있다. 그러나, 천연물 유래의 추출물을 함유하는 관련제품들의 경우 기대 수준의 탈모 방지, 발모 촉진 및 모발 개선효과를 나타내기에 미흡한 경우가 많았다.Considering such a problem, studies on a composition for preventing hair loss or for promoting hair growth, which do not have toxicity and do not cause side effects even for long-term use, have been actively studied by containing an extract derived from a natural product as an effective ingredient. However, in the case of related products containing extracts derived from natural products, there were many cases in which the antioxidant activity was not sufficient to prevent hair loss, accelerate hair growth and improve hair.

이에, 본 발명자들은, 장기간 사용에도 부작용이 전혀 없으면서도, 탈모 방지 및 발모 촉진 효과가 우수한 조성물을 예의 연구한 결과, 나팔꽃 식물의 꽃추출물을 주요 유효성분으로 함유하면서 특정 화합물을 병용하는 경우, 탈모 방지 및 발모 촉진에 현저한 효과가 있음을 밝혀, 본 발명을 완성하게 되었다.The inventors of the present invention have made intensive studies on a composition which is excellent in hair loss prevention and hair growth promoting effect even when there is no side effect in long term use. As a result, when a specific compound is used in combination with a flower extract of morning glory plant as a main active ingredient, And the effect of promoting hair growth is remarkable. Thus, the present invention has been completed.

이와 같은 나팔꽃 식물의 추출물을 모발 제품에 이용한 예로서, 한국공개특허 제2002-0050261호에는, 산초 추출물 등의 티로시나제 촉진제 등과 함께 5α-리덕타제 억제제 중 하나로서 나팔꽃 종자인 견우자의 추출물이 첨가된 탈모 방지 또는 양모용 조성물을 개시하고 있다. 그러나, 나팔꽃의 종자가 아닌 꽃추출물을 탈모 방지 및 발모 촉진 용도로 이용한다고 개시된 문헌은 아직까지 없다.As an example of using such a morning glory plant extract as a hair product, Korean Patent Laid-Open Publication No. 2002-0050261 discloses a hair loss enhancer, which is one of 5α-reductase inhibitors together with a tyrosinase promoter such as a sancho extract, Preventing or wool hair. However, there is no document yet disclosing the use of flower extracts other than morning glory seeds for hair loss prevention and hair growth promotion.

본 발명의 목적은 장기간 사용시에도 부작용이 거의 없고, 우수한 탈모 방지 및 발모 촉진 효과를 갖는, 탈모 방지 및 발모 촉진용 조성물을 제공하는 데에 있다.It is an object of the present invention to provide a composition for preventing hair loss and promoting hair growth, which has little side effects even when used for a long period of time, and has excellent hair loss prevention and hair growth promoting effect.

상기 목적을 달성하기 위하여, 본 발명은, 나팔꽃(Pharbitis nil (L.) Choisy)의 꽃추출물을 유효성분으로 함유하는 탈모 방지 및 발모 촉진용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for preventing hair loss and promoting hair growth, which comprises a flower extract of Pharbitis nil (L.) Choisy as an active ingredient.

본 발명에 있어서, 상기 나팔꽃의 꽃추출물은, 나팔꽃의 꽃을 탄소수 1 내지 4의 저급 알코올의 1종 또는 2종 이상의 혼합 용매로 추출한 것이 바람직하다.In the present invention, it is preferable that the morning flower of the morning glory flower is extracted with a mixed solvent of one or more kinds of lower alcohol having 1 to 4 carbon atoms.

또한, 본 발명은, 상기 나팔꽃의 꽃추출물에, 혈류촉진제, 히알루론산, 및 레시틴을 더 함유하는 탈모방지 및 발모 촉진용 조성물을 제공한다.The present invention also provides a composition for promoting hair loss prevention and hair growth, which further comprises a blood flow promoter, hyaluronic acid, and lecithin in the flower extract of morning glory flower.

본 발명에 있어서, 조성물 총 중량에 대하여, 상기 나팔꽃의 꽃추출물을, 고형분으로서 0.001~10중량%로 함유하는 것이 바람직하다.In the present invention, it is preferable that the morning flower of the morning glory flower is contained in an amount of 0.001 to 10% by weight based on the total weight of the composition.

또한, 본 발명에 있어서, 조성물 총 중량에 대하여, 상기 혈류촉진제를 0.0001~2중량%; 히알루론산을 0.1~10중량%; 및 레시틴을 0.001~10중량%로 함유하는 것이 바람직하다.In the present invention, 0.0001 to 2% by weight of the blood flow promoter is added to the total weight of the composition; 0.1 to 10% by weight of hyaluronic acid; And lecithin in an amount of 0.001 to 10% by weight.

본 발명에 있어서, 상기 혈류촉진제는, 일산화질소, 글루타치온, S-니트로소글루타치온, 및 S-니트로소시스테인으로 이루어진 군에서 선택된 하나 이상인 것이 바람직하다.In the present invention, it is preferable that the blood flow promoting agent is at least one selected from the group consisting of nitrogen monoxide, glutathione, S-nitrosoglutathione, and S-nitrosoxystane.

본 발명의 탈모 방지 및 발모 촉진용 조성물은, 두발, 눈썹, 속눈썹, 음모, 겨드랑이털, 가슴털, 코털, 및 다리털을 포함하는 군에서 선택된 모발에 적용될 수 있다.The hair loss prevention and hair growth promoting composition of the present invention can be applied to hair selected from the group including hair, eyebrow, eyelash, conspiracy, armpit hair, chest hair, nose hair, and leg hair.

본 발명의 탈모 방지 및 발모 촉진용 조성물은, 용액, 크림, 로션, 샴푸, 헤어토닉, 스프레이, 및 겔 중에서 선택된 형태를 갖는 것일 수 있다.The composition for preventing hair loss and promoting hair growth of the present invention may have a form selected from a solution, a cream, a lotion, a shampoo, a hair tonic, a spray, and a gel.

이하, 본 발명의 구성을 더 자세하게 설명한다.Hereinafter, the configuration of the present invention will be described in more detail.

본 발명은, 나팔꽃의 꽃추출물을 유효성분으로 함유하는 탈모 방지 및 발모 촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing hair loss and for promoting hair growth comprising a flower extract of morning glory as an active ingredient.

상기 나팔꽃은, 한해살이 덩굴식물로서, 메꽃과(Convolvulaceae)의 나팔꽃(Pharbitis nil (L.) Choisy; Ipomoea nil (L.) Roth)을 말한다. 나팔꽃은 인도 등 열대 아시아가 원산지이며 약 256 변종이 알려져 있다. 그 꽃은, 7∼8월에 푸른 자주색, 붉은 자주색, 흰색, 붉은 색 등 여러 가지 빛깔로 피고 잎겨드랑이에서 나온 꽃대에 1∼3송이씩 달린다. 꽃받침은 깊게 5개로 갈라지고, 갈라진 조각은 가늘고 길며 끝이 뾰족하고 뒷면에 긴 털이 있다. 화관은 지름이 10∼13cm이고 깔때기처럼 생겼다. 꽃봉오리는 붓끝 같은 모양으로 오른쪽으로 말려 있다. 수술은 5개, 암술은 1개이다. 열매는 꽃받침 안에 있으며 3칸으로 나누어진 둥근 삭과이다. 3칸에 각각 2개의 종자가 들어 있다. 나팔꽃의 종자는 견우자(牽牛子, Pharbitidis Semen)라 하여 약재로 많이 쓰였는데, 푸르거나 붉은 나팔꽃의 종자를 흑축(黑丑), 흰 나팔꽃의 종자를 백축(白丑)이라고 한다. 견우자를 깬 것은 약간 냄새가 있고 자극성이며 맛은 쓰고 성질은 차며 독이 있다. 견우자는 사하(瀉下)작용과 이뇨작용이 강하고 기를 잘 내려 몸이 부을 때, 만성 신우신염, 간경화 등으로 복수가 찰 때 사용한다.The morning glory is an annual plant, which means Pharbitis nil (L.) Choisy ( Ipomoea nil (L.) Roth) of Convolvulaceae. Morning glory is originated in tropical Asia, including India, and about 256 varieties are known. The flowers are bloomed in various colors such as blue purple, red purple, white, and red in July ~ August, and one to three flowers hang on the peduncle from the axilla. Calyx is deeply divided into 5 pieces, the split pieces are thin and long, pointed end, and long hairs on back side. Corolla is 10-13cm in diameter and looks like a funnel. The bud is curled to the right in the shape of a brush. There are 5 stamens and 1 pistil. The fruit is in a calyx and is a round cape divided into three chambers. Each of the three boxes contains two seeds. The seeds of morning glory are used as medicines for Pharbitidis Semen. The seeds of green or red morning glory are called black ㅇ, and the seeds of white morning glory are called white 丑. It is a bit smelly, irritating, tastes worn, cold and poisonous. It is used when the body is swollen and has a strong diuretic effect and a diuretic effect and the hypochlorous action and chronic pyelonephritis and cirrhosis when the body is poured.

본 발명에서는, 나팔꽃 식물의 꽃 부분, 즉, 화관(꽃잎 전체), 암술, 수술 및 꽃받침으로 이루어진 꽃 부분을 사용하며, 꽃을 채취하여 그대로 또는 필요에 따라 건조시킨 다음, 분쇄 또는 미분쇄 상태로 용매 추출에 제공하여 추출물을 얻게 된다.In the present invention, the flower part of the morning glory plant, that is, the flower part composed of the corolla (petal), the pistil, the stamen, the stamen and the calyx is used and the flower is taken and dried as it is or as necessary, Solvent extraction to obtain an extract.

이때 사용하는 용매는 식물로부터 당해 식물에 함유된 성분을 추출할 때 일반적으로 사용되는 용매를 선택할 수 있으며 특별히 한정되지 않는다. 예를 들면, 열수 또는 물; 메탄올, 에탄올, 이소프로필 알콜, n-부탄올 등의 저급 알콜; 프로필렌 글리콜, 1,3-부틸렌 글리콜 등의 다가 알콜; 이들 알콜류의 함수물: n-헥산, 톨루엔 등의 탄화수소계 용매 등을 들 수 있지만, 본 발명에서는 메탄올, 에탄올, 이소프로필 알콜, n-부탄올과 같이 탄소수 1 내지 4의 저급 알콜을 추출 용매로서 사용하는 것이 바람직하다. 이들 저급 알콜을 추출 용매로서 사용하는 경우, 추출물을 그대로 본 발명의 조성물 중에 배합할 수 있지만 추출 용매를 일단 증류 제거하여 필요에 따라 건조시키고 나서 배합할 수 있다.The solvent to be used herein is not particularly limited and can be selected from commonly used solvents for extracting the components contained in the plant from the plant. For example, hot water or water; Lower alcohols such as methanol, ethanol, isopropyl alcohol and n-butanol; Polyhydric alcohols such as propylene glycol and 1,3-butylene glycol; Hydrocarbons such as n-hexane and toluene. In the present invention, a lower alcohol having 1 to 4 carbon atoms such as methanol, ethanol, isopropyl alcohol and n-butanol is used as an extraction solvent . When these lower alcohols are used as the extraction solvent, the extract can be directly incorporated into the composition of the present invention, but the extraction solvent can be once removed by distillation, dried and then mixed as required.

상기 나팔꽃의 꽃추출물의 함량은, 꽃추출물의 고형분을 기준으로, 조성물 전체 중량의 0.001~10중량%을 사용하는 것이 바람직하고, 0.001~5중량%를 사용하는 것이 보다 바람직하다. 상기 나팔꽃의 꽃추출물의 함량이 0.001중량% 미만이면 탈모 방지 및 발모 촉진 효과를 충분히 발휘할 수 없으며, 10중량%를 초과하면 용량에 비례하는 효과를 얻지 못하고 제형을 유지하기가 곤란하다.The content of the morning flower of the morning glory flower is preferably 0.001 to 10% by weight, more preferably 0.001 to 5% by weight based on the solid content of the flower extract. If the content of the flower extract of morning glory flower is less than 0.001% by weight, the effect of preventing hair loss and promoting hair growth can not be sufficiently exhibited. If the content is more than 10% by weight, it is difficult to maintain the formulation.

또한, 본 발명의 조성물에는, 상기 나팔꽃의 꽃추출물에 더하여 혈류촉진제, 히알루론산, 및 레시틴을 함유할 수 있다.In addition, the composition of the present invention may contain a blood flow promoter, hyaluronic acid, and lecithin in addition to the flower morning flower of the morning glory.

상기 혈류촉진제로서는, 일산화질소, 글루타치온(glutathione), S-니트로소글루타치온(S-nitrosoglutathiones), 및 S-니트로소시스테인(S-nitrosocysteine)으로 이루어진 군에서 선택된 1종 이상을 사용하는 것이 바람직하다.As the blood flow promoter, it is preferable to use at least one selected from the group consisting of nitrogen monoxide, glutathione, S-nitrosoglutathion, and S-nitrosocysteine.

일산화 질소 (Nitric Oxide; NO)는 인체에서 NOS(Nitric Oxide Synthase)I, NOSII, NOS III에 의해 합성되며 그 상세한 조절 기작은 세포내에 mM 범위의 높은 농도로 존재하고 있는 글루타치온 (glutathione)과의 결합 혹은 아미노산 중 하나인 시스테인(cysteine)과의 결합한 상태로 작용하여, 혈관 이완에 도움을 준다. 따라서, 이러한 혈류 개선 작용을 통해 모발 성장이 촉진될 수 있고, 유효성분인 나팔꽃의 꽃추출물을 탈모 방지 또는 발모 촉진의 타겟이 되는 조직 세포 내로 용이하게 전달할 수 있는 효과도 얻을 수 있다.Nitric oxide (NO) is synthesized by NOS (Nitric Oxide Synthase) I, NOSII, and NOS III in the human body. Its detailed regulation mechanism is binding to glutathione Or cysteine (cysteine), which is one of the amino acids, to help relax the blood vessels. Therefore, the hair growth can be promoted through the blood flow improving action, and the flower extract of the morning glory flower, which is an effective ingredient, can be easily delivered into tissue cells targeted for hair loss prevention or hair growth promotion.

본 발명에서는, 나팔꽃의 꽃추출물과 함께, 상기 혈류 촉진제로서, 일산화질소를 공급할 수 있는 물질들 중 어느 하나 이상을 조합하거나 단독으로 사용함으로써, 탈모 방지 및 발모 촉진 효과가 예상치 못하게 향상하는 점을 밝혀냈다.In the present invention, it has been unexpectedly found that hair loss prevention and hair growth promoting effects are unexpectedly improved by using any one or more of the substances capable of supplying nitrogen monoxide as the blood flow promoting agent together with flowerpox extract of morning glory .

상기 혈류 촉진제는, 조성물 전체 중량의 0.0001~2.0중량%, 보다 바람직하게는, 0.0001~1.5 중량%를 사용하는 것이 바람직하다. 상기 혈류 촉진제가 0.0001중량% 미만이면, 충분한 혈류 효과를 실현시키는 것이 곤란하며, 2.0중량%를 초과하면 피부 자극이 생기는 등 안정성에 있어 문제가 있다.The blood flow promoting agent is preferably used in an amount of 0.0001 to 2.0% by weight, more preferably 0.0001 to 1.5% by weight, based on the total weight of the composition. If the blood flow promoting agent is less than 0.0001% by weight, it is difficult to realize a sufficient blood flow effect. If the blood flow promoting agent is more than 2.0% by weight, skin irritation may occur.

또한, 본 발명의 조성물은, 레시틴 혹은 그 가수분해물(hydrolysed lecithin)을 더 포함함으로써, 세포내 혈류 조절, 산화 방지, 및 리포좀 형성에 의한 유효성분의 세포 전달력 향상 등의 효과에 의해, 탈모 방지 및 발모 촉진 효과가 극대화될 수 있다.In addition, the composition of the present invention further comprises lecithin or a hydrolysed lecithin thereof, whereby the effect of controlling intracellular blood flow, preventing oxidation, and enhancing cell delivery ability of the active ingredient by liposome formation, And hair growth promoting effect can be maximized.

본 발명에서 사용되는 레시틴은, 주로 난황 또는 대두에서 추출한 후 정제하여 제조한 것으로, 포스파티딜콜린(phosphatidylcholine), 포스파티딜세린(phosphatidylserine), 포스파티딜에탄올아민(phosphatidylethanolamine), 포스파티딜글리콜(phosphatidylglycol), 포스파티드산(phosphatidic acid) 및 수소첨가 포스파티딜콜린(hydrogenated phosphatidylcholine) 등의 인지질류로 구성되며, 레시틴의 가수분해물은, 레시틴을 가수분해하여 생성되는 콜린, 인산, 글리세롤, 지방산을 말한다.The lecithin used in the present invention is prepared by extracting from egg yolk or soybean and then purified. The lecithin used in the present invention is a phosphatidylcholine, a phosphatidylserine, a phosphatidylethanolamine, a phosphatidylglycol, a phosphatidic acid, acid and hydrogenated phosphatidylcholine, and the hydrolyzate of lecithin refers to choline, phosphoric acid, glycerol, and fatty acids produced by hydrolysis of lecithin.

상기 레시틴 혹은 그 가수분해물(hydrolysed lecithin)은, 조성물 전체 중량의 0.001~10중량%을 포함하는 것이 바람직하며, 0.001~5중량%를 포함하는 것이 보다 바람직하다.The lecithin or the hydrolysed lecithin preferably contains 0.001 to 10% by weight, more preferably 0.001 to 5% by weight, of the total weight of the composition.

또한, 본 발명에서는, 히알루론산(Hyaluronic acid: HA)을 나팔꽃의 꽃추출물과 혈류개선 촉진제와 조합하여 사용함으로써, 히알루론산의 영양성분 확산 작용에 기인하여 약물전달 체계 (DDS; Drug delivery system)로 작용하고, 더 나아가 산화를 방지해주는 기능과 더불어, 나팔꽃의 꽃추출물과 혈류개선 촉진제를 원활하게 두피조직 세포로 공급하여 탈모 방지 및 발모 촉진 효과를 극대화할 수 있는 효과가 있다.In addition, in the present invention, by using hyaluronic acid (HA) in combination with a flower extract of morning glory flower and a blood flow improvement promoter, a drug delivery system (DDS) In addition to the function of preventing oxidization, the flower extract of morning glory and the blood flow improvement promoter are smoothly supplied to the scalp tissue cells, thereby maximizing the effect of preventing hair loss and promoting hair growth.

상기 히알루론산은, 조성물 전체 중량의 0.1~10중량%, 보다 바람직하게는, 0.5~5중량%로 사용하는 것이 바람직하다.The hyaluronic acid is preferably used in an amount of 0.1 to 10% by weight, more preferably 0.5 to 5% by weight, based on the total weight of the composition.

본 발명의 조성물의 적용 대상이 되는 모발로는, 두발(頭髮), 눈썹(眉毛, 미모), 속눈썹(睫毛, 첩모), 음모(陰毛), 겨드랑이털, 가슴털, 코털, 및 다리털 등의 각종 체모가 포함될 수 있다.Examples of the hair to which the composition of the present invention is applied include head hair, eyebrow hair, eyelashes, eyelashes, pubic hair, underarm hair, chest hair, nose hair, Various hairs may be included.

본 발명의 바람직한 구현 예에 따르면, 본 발명의 조성물은 약제학적 조성물, 화장료 조성물로 제공될 수 있다.According to a preferred embodiment of the present invention, the composition of the present invention may be provided as a pharmaceutical composition or a cosmetic composition.

본 발명의 조성물이 약제학적 조성물로 제조되는 경우, 본 발명의 약제학적 조성물은 약제학적으로 허용되는 담체를 포함한다. 상기 약제학적으로 허용되는 담체는 제제시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산 칼슘, 알기네이트, 젤라틴, 규산 칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 정제수, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. 본 발명의 약제학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등과 같이 통상적으로 이용되는 첨가제를 추가로 포함할 수 있다. 본 발명의 약제학적 조성물은 경구 또는 비경구 투여할 수 있으며, 바람직하게는 비경구 투여, 보다 바람직하게는 도포에 의한 국소 투여 방식으로 적용된다.When the composition of the present invention is manufactured from a pharmaceutical composition, the pharmaceutical composition of the present invention includes a pharmaceutically acceptable carrier. Such pharmaceutically acceptable carriers are those conventionally used in the field of manufacture and include lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, But are not limited to, polyvinylpyrrolidone, cellulose, purified water, syrup, methylcellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. The pharmaceutical composition of the present invention may further contain additives commonly used such as lubricants, wetting agents, sweetening agents, flavoring agents, emulsifying agents, suspending agents, preservatives and the like in addition to the above components. The pharmaceutical composition of the present invention can be administered orally or parenterally, and is preferably administered by parenteral administration, more preferably by topical administration by application.

본 발명의 약제학적 조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다.The appropriate dosage of the pharmaceutical composition of the present invention may vary depending on factors such as the formulation method, administration method, age, body weight, sex, pathological condition, food, administration time, administration route, excretion rate, .

본 발명의 조성물에 포함된 유효성분인 나팔꽃의 꽃추출물의 투여량은 성인 기준으로 0.001~100mg/kg, 바람직하게는 0.1~100mg/kg, 보다 바람직하게는 1~50mg/kg이며, 상기 투여량을 하루에 한번 또는 수회 나누어 투여할 수도 있다.The dose of the flower extract of morning glory which is an active ingredient contained in the composition of the present invention is 0.001 to 100 mg / kg, preferably 0.1 to 100 mg / kg, more preferably 1 to 50 mg / kg on an adult basis, May be administered once or several times a day.

본 발명의 약제학적 조성물은 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 오일 또는 수성 매질중의 용액, 현탁액, 시럽제 또는 유화액, 엑스제, 산제, 분말제, 과립제, 정제 또는 캅셀제 형태로 제조될 수 있으며, 분산제 또는 안정화제를 추가적으로 포함할 수 있다.The pharmaceutical composition of the present invention may be formulated as a solution, suspension, syrup or emulsion, excipient, powder or powder in an oil or an aqueous medium according to a method which can be easily carried out by a person having ordinary skill in the art to which the present invention belongs Granules, tablets or capsules, and may additionally contain a dispersant or stabilizer.

본 발명의 조성물이 모발용 화장료로 제조되는 경우, 본 발명의 조성물은 그 유효성분인 나팔꽃의 꽃추출물, 혈류개선 촉진제, 히알루론산, 및 레시틴 뿐만 아니라, 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다. 또한, 본 발명의 조성물은 상술한 유효성분 이외에, 본 발명의 유효성분에 의한 탈모 방지 및 발모 촉진 작용을 손상시키지 않는 한도에서 종래부터 사용되어 오던 발모제 또는 탈모방지제를 함께 혼합하여 사용할 수 있다.When the composition of the present invention is made of a hair cosmetic composition, the composition of the present invention includes not only the flower extract of morning glory, the blood flow improvement promoter, hyaluronic acid, and lecithin, which are effective ingredients thereof, but also components commonly used in cosmetic compositions, Such as antioxidants, stabilizers, solubilizers, vitamins, customary adjuvants such as pigments and flavoring agents, and carriers. The composition of the present invention can be used in combination with a hair growth inhibitor or an antiloading agent which has been conventionally used as long as it does not impair the hair loss prevention and hair growth promoting action by the active ingredient of the present invention.

상기 담체로서, 정제수, 일가 알코올류(에탄올 또는 프로필 알코올), 다가 알코올류(글리세롤, 1,3-부티렌글리콜 또는 프로필렌글리콜), 고급 지방산류(팔미틸산 또는 리놀렌산), 유지류(소맥 배아유, 동백기름, 호호바유, 올리브유, 스쿠알렌, 해바라기유, 마카데미아땅콩유, 아보가드유, 또는 지방산 글리세라이드) 등을 사용할 수 있으나, 이에 한정되지는 않는다. 또한, 필요에 따라, 계면활성제, 보습제, 방부제, 산화방지제 등을 첨가할 수 있다.As the carrier, it is possible to use purified water, monohydric alcohols (ethanol or propyl alcohol), polyhydric alcohols (glycerol, 1,3-butylene glycol or propylene glycol), higher fatty acids (palmitic acid or linolenic acid) But are not limited to, camellia oil, jojoba oil, olive oil, squalane, sunflower oil, macadamia peanut oil, avocado oil, or fatty acid glyceride). If necessary, surfactants, moisturizers, preservatives, antioxidants and the like may be added.

본 발명의 화장료 조성물에 사용될 수 있는 계면활성제로는, 음이온계 계면활성제로서, 알킬벤젠설폰산염, 폴리옥시알킬렌알킬황산 에스테르염, 알킬황산 에스테르염, 올레핀설폰산염, 알킬인산염, 폴리옥시알킬렌알킬에테르인산염, 디알킬설포석신산염, 지방산염 등을 들 수 있고, 비이온성 계면활성제로서, 폴리옥시에틸렌알킬에테르, 폴리옥시에틸렌지방산 에스테르, 다가 알콜지방산 부분 에스테르, 폴리옥시에틸렌 다가 알콜지방산 부분 에스테르, 폴리글리세린지방산 에스테르, 폴리옥시에틸렌 경화 피마자유 유도체, 지방산디에탄올아미드 등을 들 수 있다. 또한, 양이온성 계면활성제로서는, 3급 지방족 아민염, 알킬트리메틸암모늄할라이드, 디알킬디메틸암모늄할라이드 등을 들 수 있고, 양쪽성 계면활성제로서는, 아미드베타인형, 이미다졸리늄베타인형, 설포베타인형 등을 들 수 있다.Examples of the surfactant that can be used in the cosmetic composition of the present invention include anionic surfactants such as alkylbenzenesulfonates, polyoxyalkylene alkylsulfate ester salts, alkylsulfate ester salts, olefin sulfonates, alkyl phosphates, polyoxyalkylene Alkyl ether phosphates, dialkyl sulfosuccinates, fatty acid salts, and the like. Nonionic surfactants include polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyhydric alcohol fatty acid partial esters, polyoxyethylene polyhydric alcohol fatty acid moieties Esters, polyglycerin fatty acid esters, polyoxyethylene hydrogenated castor oil derivatives, and fatty acid diethanolamides. Examples of the cationic surfactant include tertiary aliphatic amine salts, alkyltrimethylammonium halides and dialkyldimethylammonium halides. Examples of the amphoteric surfactants include amide betaine, imidazolinium betaine, sulfobetaine, And the like.

상기 보습제로서는, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 디프로필렌글리콜, 소르비톨 등을 들 수 있다.Examples of the moisturizing agent include glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, and sorbitol.

상기 방부제로서는, 벤조산, 데하이드로아세트산, 파라옥시벤조산에스테르(파라옥시벤조산메틸, 파라옥시벤조산부틸 등), 페녹시에탄올 등을 들 수 있다.Examples of the preservative include benzoic acid, dehydroacetic acid, paraoxybenzoic acid esters (such as methyl parahydroxybenzoate, butyl parahydroxybenzoate), and phenoxyethanol.

또한, 상기 산화방지제로서는, 아스코르브산, BHA 등을 들 수 있으며, 이외에도, 자외선 흡수제, 소염제 및 청량제 등을 첨가할 수 있다.Examples of the antioxidant include ascorbic acid and BHA. In addition, an ultraviolet absorber, an anti-inflammatory agent, and a refreshing agent may be added.

본 발명 조성물의 제형은 그 유효성분과 배합할 수 있는 임의의 제형으로서 탈모방지 또는 발모용 화장품의 형태로는 헤어토닉, 헤어크림, 헤어로션, 헤어샴푸, 헤어린스, 헤어컨디셔너, 헤어스프레이, 헤어에어졸, 포마드, 분말, 젤 등과 같이 용액, 솔젤, 에멀젼, 오일, 왁스, 에어졸 등 다양한 형태로 제조될 수 있으나 이들로 제한되는 것은 아니다.The formulation of the composition of the present invention may be any formulations that can be combined with the active ingredient, and examples of the form of hair loss prevention or hair growth include hair tonic, hair cream, hair lotion, hair shampoo, hair conditioner, hair conditioner, hair spray, Such as, but not limited to, solutions, sols gels, emulsions, oils, waxes, aerosols, and the like, such as powders,

본 발명의 조성물은, 나팔꽃의 꽃추출물을 유효성분으로 함유함으로써, 탈모 방지 및 발모 촉진에 우수한 효과를 나타내었다.The composition of the present invention has an excellent effect in preventing hair loss and promoting hair growth by containing a flower extract of morning glory as an active ingredient.

또한, 본 발명의 조성물은, 나팔꽃의 꽃추출물에, 혈류촉진제, 히알루론산, 및 레시틴을 조합하는 구성에 의해, 탈모 방지와 함께 발모 촉진 및 두피 개선에 우수한 효과를 나타내었으며, 장기간 사용에도 부작용을 유발하지 않았다.In addition, the composition of the present invention shows excellent effects on preventing hair loss and promoting hair growth and scalp by combining a flower flowering extract of morning glory flower, a blood flow promoter, hyaluronic acid, and lecithin. Did not induce.

도 1 내지 3은, 본 발명의 실시예 1의 조성물(1a, 1b, 1c), 대조군으로서 비교예 1의 정제수(2a, 2b, 2c), 양성대조군으로서 비교예 2의 마이녹실(3a, 3b, 3c)을 C57BL/6 마우스의 제모된 피부에 도포한 후 각각 0일째, 10일째, 20일째 디지털 카메라로 촬영한 결과이다.1 to 3 show the compositions (1a, 1b and 1c) of Example 1 of the present invention, the purified water (2a, 2b and 2c) of Comparative Example 1 as a control group, 3c) were applied to the epilated skin of C57BL / 6 mice and photographed with a digital camera on day 0, day 10, and day 20, respectively.

이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해질 수 있도록 그리고 당업자에게 본 발명의 사상이 충분히 전달될 수 있도록 하기 위해 제공되는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein but may be embodied in other forms. Rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the concept of the invention to those skilled in the art.

제조예 1: 나팔꽃의 꽃추출물의 제조Production Example 1: Preparation of flower extract of morning glory

나팔꽃 식물(Pharbitis nil (L.) Choisy)의 꽃 200g을 수세하고 건조시켜 분말로 한 다음, 70% 에탄올 수용액 1000ml에 넣고, 4~35 ℃에서 1~6 시간 동안 유지한 후 여과하고, 여과된 추출물을 감압농축하였다. 농축된 시료를 동결건조기를 이용하여 건조한 후 4.2g(수득률 2.1%)의 나팔꽃의 꽃추출물을 얻었다.200 g of a flower of a morning glory plant ( Pharbitis nil (L.) Choisy) was washed with water and dried to obtain a powder. The powder was then added to 1000 ml of a 70% aqueous ethanol solution, maintained at 4 to 35 ° C for 1 to 6 hours, The extract was concentrated under reduced pressure. The concentrated sample was dried using a freeze dryer to obtain 4.2 g (2.1% yield) morning glory flower extract.

제조예 2: 나팔꽃의 종자추출물(견우자 추출물)의 제조Production Example 2: Preparation of seed extract of morning glory (strawberry extract)

나팔꽃 식물(Pharbitis nil (L.) Choisy)의 종자 200g을 건조시켜 분말로 한 다음, 70% 에탄올 수용액 1000ml에 넣고, 4~35 ℃에서 1~6 시간 동안 유지한 후 여과하고, 여과된 추출물을 감압농축하였다. 농축된 시료를 동결건조기를 이용하여 건조한 후, 4g(수득률 2%)의 나팔꽃의 종자추출물을 얻었다.200g of seeds of morning glory plant ( Pharbitis nil (L.) Choisy) were dried and put into 1000ml of 70% ethanol solution, kept at 4 ~ 35 ℃ for 1 ~ 6 hours, filtered and the filtered extract And concentrated under reduced pressure. The concentrated sample was dried using a freeze dryer, and 4 g (2% yield) of morning glory seed extract was obtained.

제조예 3: 실시예 1, 및 비교예 1 내지 3Production Example 3: Example 1 and Comparative Examples 1 to 3

하기 표 1의 조성에 따라, 실시예 1, 및 비교예 3의 조성물을 제조하였다. 또한, 비교예 1로서 정제수를 준비하였고, 비교예 2로서 마이녹실 5%액(현대약품, 미녹시딜 50mg/mL)을 준비하였다.The compositions of Example 1 and Comparative Example 3 were prepared according to the compositions shown in Table 1 below. In addition, purified water was prepared as Comparative Example 1, and 5% solution of minoxynil (Hyundai Pharmaceutical, Minoxidil 50 mg / mL) was prepared as Comparative Example 2.

Figure pct00001
Figure pct00001

실험예 1: 마우스를 이용한 발모 촉진 효과 확인Experimental Example 1: Promoting hair growth promoting effect using mouse

1) 실험동물의 준비 및 조성물의 도포1) Preparation of experimental animals and application of composition

생후 5주된 수컷 C57BL/6 마우스(코아텍(주))를, 온도(21~23℃), 습도(40~60%), 조명(12시간 명/암)이 자동적으로 유지되는 사육실에서 1주일 동안 적응시켜 안정기를 거쳐 실험에 사용하였다.A 5-week-old male C57BL / 6 mouse (Coatec Co., Ltd.) was housed in a feeding room where temperature (21 to 23 ° C), humidity (40 to 60% And then used in the experiment through a ballast.

즉, 6주령이 된 C57BL/6 마우스를 에틸에테르 또는 조레틸 50(Zoletil 50)을 생리식염수로 8배 희석한 후, 1mL주사기로 0.2mL 복강주사하여 마취시킨 후, 동물용 털깎기(pet clipper(JP-6751) 조아스 애견용 이발기)를 사용하여 제거한 다음, 제모제(니크린 크림, 일동제약)를 사용하여 나머지 털을 완전히 제거하고, 깨끗이 닦아주었다.That is, C57BL / 6 mice at 6 weeks of age were diluted 8 times with ethyl ether or Zolethyl 50 with physiological saline, and anesthetized by intraperitoneal injection of 0.2 mL with a 1 mL syringe. Then, an animal clipper (JP-6751) Joas dog hair clipper), and the hair was completely removed using a depilator (Nitrin cream, Ildong Pharma) and cleaned thoroughly.

상기 마우스를 각 그룹당 7마리씩 나눈 후, 실시예 1, 및 비교예 1 및 2의 조성물을 각 개체별로 0.25mL씩 제모한 부분에 분사하여 골고루 도포하였으며, 매일 오전 10시에 1회씩 3주 동안 도포하면서 관찰하였다.The mice were divided into 7 mice per each group and sprayed on the hair removal portions of 0.25 mL each of the compositions of Example 1 and Comparative Examples 1 and 2. The mice were sprayed evenly at 10 o'clock every morning for 3 weeks Respectively.

2) 실험동물에서의 발모 효과 관찰 결과2) Observation of hair growth effect in experimental animals

실시예 1, 및 비교예 1 및 2의 조성물을 도포한 마우스의 발모상태를 확인하기 위하여, 실험개시 0일째, 10일째, 및 20일째에 육안 관찰과 함께 디지털 카메라를 이용하여 발모부위를 촬영하였다.In order to confirm the hair growth state of the mice to which the composition of Example 1 and Comparative Examples 1 and 2 were applied, the hairs were photographed using a digital camera with visual observation on the 0th day, the 10th day, and the 20th day of the experiment .

그 결과, 실시예 1의 조성물을 도포한 실험군에서는, 도포 10일째, 제모되었던 피부의 전체 부위가 회색으로 보이며, 모발이 상대적으로 더 자란 부분이 드문드문 검게 보이는 발모현상이, 7마리 모두에서 나타남을 확인할 수 있었다(도 1b 참조). 또한, 도포 20일째에는, 제모되기 전의 상태에 근접하게 모발이 성장하였음을 확인할 수 있었다(도 1c 참조).As a result, in the experimental group to which the composition of Example 1 was applied, on the 10th day of application, the whole skin of the epilated skin appeared gray, and the hair growth phenomenon where the hair was relatively grown was sparsely black appeared in all 7 animals (See FIG. 1B). On the 20th day after application, it was confirmed that hair was grown close to the state before hair removal (see Fig. 1C).

한편, 대조군으로서, 비교예 1의 정제수를 도포한 실험군에서는, 도포 10일째, 발모현상이 나타나기는 하였으나(도 2b 참조) 발모가 진행되지 않은 부분도 있어, 실시예 1의 도포 10일째와는 확연히 차이가 있었고, 도포 20일째에는 피부가 회색으로 보이며, 부분적으로 검은색 모발이 짧게 성장한 상태인 점(도 2c)을 확인할 수 있었었다. 또한, 비교예 2의 마이녹실을 도포한 실험군의 마우스는, 10일째에는, 제모되었던 피부의 전체 부위가 회색으로 보이는 발모현상이 나타났고(도 3b 참조), 20일째에는 모발이 성장하기는 하였으나, 그 정도가 비교예 1보다는 약간 길면서, 실시예 1 보다는 훨씬 짧은 수준이었다(도 3c 참조).On the other hand, in the experimental group to which the purified water of Comparative Example 1 was applied as the control group, hair growth was observed on the 10th day after application (see FIG. 2B), but hair growth was not progressed. There was a difference. On the 20th day after application, the skin appeared to be gray and partially black hair was short grown (Fig. 2C). In addition, in the mouse of the experimental group to which the minoxil of Comparative Example 2 was applied, a hair growth phenomenon in which the entire skin of the epilated skin appeared gray appeared on the 10th day (see Fig. 3b) The degree was slightly longer than that of Comparative Example 1, and was much shorter than that of Example 1 (see FIG. 3C).

또한, 도포 20일째에 제모 부위에 새로 성장한 각 마우스의 모발을 동물용 털깎기(pet clipper(JP-6751)로 수거하여 그 중량을 측정하고, 제모 직전의 모발 중량과 비교했을 때의 회복 정도를 5단계로 분류 판정하여, 모발 성장 촉진 효과를 평가해 보았는 바, 그 결과는 다음과 같다.On the 20th day after the application, hair of each mouse newly grown in the hair removal area was collected with an animal hair clipper (JP-6751), and the weight thereof was measured. The degree of recovery in comparison with the hair weight immediately before hair removal The results were as follows. The results were as follows.

Figure pct00002
Figure pct00002

위와 같은 육안 관찰 결과, 본 발명의 조성물은, 종래 탈모에 사용되는 마이녹실에 비해서도 훨씬 우수한 발모 촉진 효과를 나타냄을 확인할 수 있었다.As a result of the above-mentioned visual observation, it was confirmed that the composition of the present invention exhibits a hair growth promoting effect which is far superior to that of minoxynil used in conventional hair loss.

실험예 2: 임상실험을 통한 탈모 방지 및 발모 촉진 효과 평가Experimental Example 2: Estimation of hair loss prevention effect and hair growth promoting effect through clinical experiment

1) 임상실험 방법1) Clinical test method

실시예 1, 및 비교예 2 및 3의 조성물의 발모 효과를 확인하기 위하여, 탈모증이 있는 대상자를 선정하여 임상실험을 하였다. 즉, 탈모증이 있는 30~50세의 성인남녀 총 30명을 대상으로 남성 5명, 여성 5명을 한 그룹으로 나누어 1일 1회, 1회에 2ml씩 4개월간 탈모부위에 도포하여 그 결과를 관찰하였다.In order to confirm the hair growth effect of the composition of Example 1 and Comparative Examples 2 and 3, clinical subjects were selected by subjects having alopecia. That is, a total of 30 adult male and female 30 to 50 year olds with alopecia were divided into a group of 5 males and 5 females and applied 2 ml per day to the depilation area for 4 months, Respectively.

2) 임상실험 결과2) Clinical results

탈모 방지 및 발모 효과 여부의 판정은 세발시 일일 평균 탈모량, 육안 판정소견 및 자각 증상 개선 정도를 평가 척도로 하여 5단계로 평가하고(표 3 참조), 종합적인 개선도를 상기 평가 척도의 평균으로 하였는데, 그 점수는 5점 만점으로 단계에 따라 1점 단위로 부여하였는데, 임상실험 결과는 표 3과 같다.The evaluation of hair loss prevention and hair removal effect was made by evaluating the daily average amount of hair loss, glance determination, and improvement of subjective symptoms at the time of shaving in 5 stages (see Table 3) , And the score was given as a score of 5 points. The results of clinical trials are shown in Table 3.

Figure pct00003
Figure pct00003

Figure pct00004
Figure pct00004

상기 [표 4]에서 확인되는 바와 같이, 본 발명의 조성물은, 비교예 2 및 비교예 3에 비하여, 육안 판정, 자각 증상 및 세발시 탈모수에 있어서, 전체적으로 탈모 개선 효과를 보였다. 종합 판정 점수로 비교해 보면, 본 발명의 조성물인 실시예 1은, 비교예 2 또는 비교예 3의 조성물 대비 평균 175~200% 정도의 개선효과가 있는 것으로 확인되었다.As can be seen from the above Table 4, the composition of the present invention exhibited the hair loss improving effect as a whole in comparison with Comparative Example 2 and Comparative Example 3 in terms of visual determination, subjective symptoms, and hair loss at the time of hair loss. Comparing the results with the total judgment scores, it was confirmed that Example 1, which is the composition of the present invention, has an improvement of about 175-200% on average compared with the composition of Comparative Example 2 or Comparative Example 3.

또한, 임상실험 기간 동안 실시예 1의 조성물을 사용한 대상자 전원에게서 어떠한 부작용도 발견되지 않아 인체에도 안전한 조성물임을 알 수 있었다.In addition, during the clinical experiment period, no adverse effects were found in all the subjects using the composition of Example 1, and it was found that the composition was safe for human body.

실험예 3. 피부 자극 시험Experimental Example 3: Skin irritation test

1) 시험방법1) Test method

건강한 성인 남녀 20 명을 대상으로 패치를 이용하여 피부 자극 실험을 실시하였다. 10 % SDS(Sodium Dodecyl Sulfate) 용액을 양성 대조군으로 사용하였으며, 10 % SDS 와 실시예 1의 조성물을 1 : 1 비율로 패치에 도포하여 피험자의 복부에 부착하고, 24 시간 후 자극 정도를 판정하였다. 음성대조군으로는 증류수를 사용하였다.Twenty healthy men and women were subjected to skin stimulation tests using patches. 10% SDS (Sodium Dodecyl Sulfate) solution was used as a positive control, 10% SDS and the composition of Example 1 were applied to the patch at a ratio of 1: 1, adhered to the abdomen of the subject, and the degree of stimulation after 24 hours was determined . Distilled water was used as negative control group.

<자극성 판정><Irritability determination>

3: 강한 염증 반응3: Strong inflammatory response

2: 홍반 현상과 약간의 염증2: erythema and slight inflammation

1: 약간의 홍반 현상1: slight erythema

0: 변화없음0: No change

2) 시험결과2) Test result

양성 대조군인 10% SDS에서의 자극성 지수 평균이 2.65인데 반해, 실시예 1의 조성물과 10% SDS를 1:1로 처리할 경우, 0.30으로 자극성이 거의 없는 것으로 확인되었다.When the composition of Example 1 was mixed with 10% SDS at a ratio of 1: 1, the irritation index was found to be almost 0.30, whereas the irritation index average in the positive control group 10% SDS was 2.65.

Figure pct00005
Figure pct00005

제형예 1: 피부외용 연고의 제조Formulation Example 1: Preparation of ointment for external use

하기 표 6과 같은 조성으로 피부외용 연고를 통상의 방법에 따라 조제하였다.Skin external ointment was prepared according to a conventional method with the composition shown in Table 6 below.

Figure pct00006
Figure pct00006

제형예 2: 샴푸의 제조Formulation Example 2: Preparation of shampoo

하기 표 7과 같은 조성으로 샴푸를 통상의 방법에 따라 제조하였다.Shampoos were prepared according to the usual methods with the compositions shown in Table 7 below.

Figure pct00007
Figure pct00007

제형예 3: 헤어토닉의 제조Formulation Example 3: Production of hair tonic

하기 표 8과 같은 조성으로 헤어토닉을 통상의 방법으로 제조하였다.doing A hair tonic was prepared by the usual method with the composition shown in Table 8.

Figure pct00008
Figure pct00008

Claims (7)

나팔꽃(Pharbitis nil (L.) Choisy)의 꽃추출물을 유효성분으로 함유하는 탈모 방지 및 발모 촉진용 조성물.A composition for preventing hair loss and promoting hair growth, comprising a flower extract of Pharbitis nil (L.) Choisy as an active ingredient. 제 1 항에 있어서,
상기 나팔꽃의 꽃추출물은, 나팔꽃의 꽃을 탄소수 1 내지 4의 저급 알코올의 1종 또는 2종 이상의 혼합 용매로 추출한 것을 특징으로 하는 탈모 방지 및 발모 촉진용 조성물.
The method according to claim 1,
Wherein the morningflower flower extract is obtained by extracting flowers of morning glory flower with a mixed solvent of one or more of lower alcohols having 1 to 4 carbon atoms.
제 1 항에 있어서,
상기 탈모 방지 및 발모 촉진용 조성물은,
혈류촉진제;
히알루론산; 및
레시틴;
을 더 포함하는 것을 특징으로 하는 탈모 방지 및 발모 촉진용 조성물.
The method according to claim 1,
The composition for preventing hair loss and promoting hair growth,
Blood flow promoters;
Hyaluronic acid; And
lecithin;
The composition for preventing hair loss and promoting hair growth according to claim 1,
제 3 항에 있어서,
상기 탈모 방지 및 발모 촉진용 조성물은, 조성물 전체 중량에 대하여,
나팔꽃의 꽃추출물을 고형분으로서 0.001~10중량%;
혈류촉진제를 0.0001~2중량%;
히알루론산을 0.1~10중량%; 및
레시틴을 0.001~10중량%;
로 함유하는 것을 특징으로 하는 탈모 방지 및 발모 촉진용 조성물.
The method of claim 3,
The composition for preventing hair loss and promoting hair growth may comprise,
0.001 to 10% by weight of a morning flower of a flower extract as a solid component;
0.0001 to 2% by weight of a blood flow promoter;
0.1 to 10% by weight of hyaluronic acid; And
0.001 to 10% by weight of lecithin;
Wherein the composition for preventing hair loss and for promoting hair growth is characterized by comprising
제 3 항 또는 제 4 항에 있어서,
상기 혈류촉진제는, 일산화질소, 글루타치온, S-니트로소글루타치온, 및 S-니트로소시스테인으로 이루어진 군에서 선택된 하나 이상인 것을 특징으로 하는 탈모 방지 및 발모 촉진용 조성물.
The method according to claim 3 or 4,
Wherein the blood flow promoting agent is at least one selected from the group consisting of nitrogen monoxide, glutathione, S-nitrosoglutathione, and S-nitrosoxystane.
제 1 항 내지 제 4 항 중 어는 한 항에 있어서,
상기 탈모 방지 및 발모 촉진용 조성물은,
모발, 눈썹, 속눈썹, 음모, 겨드랑이털, 가슴털, 코털, 및 다리털을 포함하는 군에서 선택된 모발에 적용되는 것을 특징으로 하는 탈모 방지 및 발모 촉진용 조성물.
The method according to one of claims 1 to 4,
The composition for preventing hair loss and promoting hair growth,
Wherein the composition is applied to hair selected from the group consisting of hair, eyebrows, eyelashes, intrigue, underarm hair, chest hair, nose hair, and leg hair.
제 1 항 내지 제 4 항 중 어느 한 항에 있어서,
상기 탈모 방지 및 발모 촉진용 조성물은, 용액, 크림, 로션, 샴푸, 헤어토닉, 스프레이, 및 겔 중에서 선택된 형태를 갖는 것을 특징으로 하는 탈모 방지 및 발모 촉진용 조성물.
5. The method according to any one of claims 1 to 4,
Wherein the composition for preventing hair loss and promoting hair growth has a form selected from a solution, a cream, a lotion, a shampoo, a hair tonic, a spray, and a gel.
KR1020157031360A 2013-05-22 2013-05-22 Pharbitis nil (l.) choisy extract-containing composition for preventing hair loss and promoting hair growth KR101733552B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2013/004474 WO2014189159A1 (en) 2013-05-22 2013-05-22 Pharbitis nil (l.) choisy extract-containing composition for preventing hair loss and promoting hair growth

Publications (2)

Publication Number Publication Date
KR20160021086A true KR20160021086A (en) 2016-02-24
KR101733552B1 KR101733552B1 (en) 2017-05-12

Family

ID=51933703

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157031360A KR101733552B1 (en) 2013-05-22 2013-05-22 Pharbitis nil (l.) choisy extract-containing composition for preventing hair loss and promoting hair growth

Country Status (2)

Country Link
KR (1) KR101733552B1 (en)
WO (1) WO2014189159A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180100945A (en) 2017-03-03 2018-09-12 서울대학교병원 Composition for promoting hair growth comprising peptide derived from adiponectin
KR20190005426A (en) * 2017-07-06 2019-01-16 농업회사법인(주)힐리안 Composition for improving hair and scalp comprising nitric oxide-containing water and herbal extracts and manufacturing method thereof
WO2020050428A1 (en) 2018-09-03 2020-03-12 (주)정진호이펙트 Composition for promoting hair growth comprising adiponectin-derived peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100313832B1 (en) * 1999-06-14 2001-11-15 배일주 Health supplementary food using pharbitis nilchoisy and pharbitis semon
WO2001034102A1 (en) * 1999-11-08 2001-05-17 Shiseido Company, Ltd. Scalp and hair care compositions
JP2007008965A (en) 2006-10-23 2007-01-18 Pola Chem Ind Inc Hair growing agent
KR100958496B1 (en) * 2008-02-25 2010-05-17 (주)에이티 랩 Composition from natural origin ingridient for hair loss prevention and hair growth effect
KR101146262B1 (en) * 2010-01-28 2012-05-15 주식회사 바이오에프디엔씨 Composition for Skin External Application Comprising Extract of Pharbitis nil Callus

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180100945A (en) 2017-03-03 2018-09-12 서울대학교병원 Composition for promoting hair growth comprising peptide derived from adiponectin
KR20190005426A (en) * 2017-07-06 2019-01-16 농업회사법인(주)힐리안 Composition for improving hair and scalp comprising nitric oxide-containing water and herbal extracts and manufacturing method thereof
WO2020050428A1 (en) 2018-09-03 2020-03-12 (주)정진호이펙트 Composition for promoting hair growth comprising adiponectin-derived peptide
US11771636B2 (en) 2018-09-03 2023-10-03 Jungjinho Effect Inc. Composition for promoting hair growth comprising adiponectin-derived peptide

Also Published As

Publication number Publication date
KR101733552B1 (en) 2017-05-12
WO2014189159A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
KR100769260B1 (en) Compositions for hair improvement containing rare earth elements
KR100992565B1 (en) Topical preparations for hair growth
US20120107427A1 (en) Composition for promoting adipocyte differentiation containing an extract of rehmannia glutinosa, licorice, coicis semen, hordei fructus, chaenomelis fructus, acanthopanacis cortex or puerariae radix
WO2008023960A1 (en) Uses of rare earth elements for hair improvement
KR20130032788A (en) Peptides for promotion of hair growth and the use thereof
KR101686008B1 (en) Composition comprising extract of herbal mixture for preventing alopecia or hair growth effect
KR101733552B1 (en) Pharbitis nil (l.) choisy extract-containing composition for preventing hair loss and promoting hair growth
KR20210058772A (en) Composition for treating hair loss and promoting hair growth
KR101792402B1 (en) Hair growth stimulants comprising nicotinic acid adenine dinucleotide phosphate and its derivatives
ES2584931T3 (en) Composition containing the association of 2,4-diaminopyrimidine 3-N-oxide and madecasoside and / or terminoloside; use of the association to induce and / or stimulate the growth of these human keratin fibers and / or slow their fall
US20160354293A1 (en) Composition for promoting hair growth or preventing hair loss
JP5754565B2 (en) Hair restorer composition, effect enhancer for hair restorer and method for producing hair restorer
US10016351B2 (en) Composition for promoting hair growth or preventing hair loss
ES2290415T3 (en) CAPILLARY COMPOSITION CONTAINING AN N-OXIDE COMPOUND OF PYRIMIDINE, ITS USE TO STIMULATE THE GROWTH OF KERATIN FIBERS AND / OR STOP YOUR FALL.
KR100681699B1 (en) Hair Cosmetic Composition for Treating Dandruff Comprising Mung Bean Extract as Active Ingredient
KR102531790B1 (en) Composition for skin regeneration and wound healing comprising the extract of Asparagus lucidus as an active ingredient
US20200085896A1 (en) Combination of aqueous extracts of watercress and nasturtium and atp for use in the treatment of alopecia
EP4344696A1 (en) Functional composition for alopecia comprising centipeda minima-derived extract
KR102360927B1 (en) Composition for preventing hair loss and promoting hair growth comprising runcinatside
RU2794988C1 (en) Composition for stimulating hair growth and preventing hair loss
TWI353249B (en) Hair growth agent composition
KR20090090758A (en) Composition for preventing hair loss or promoting hair generation
KR101577053B1 (en) A composition for promoting hair growth and hair loss prevention containing triazole derivatives and cosmetic composition for promoting hair growth hair and loss prevention
KR20160116721A (en) Composition for prevention of hair loss or promotion of hair growth containing assam extract and/or isodon japonicus extract
KR20150051075A (en) A body hair growth inhibition composition comprising palmatine as an effective ingredient

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
GRNT Written decision to grant